Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Novartis aims for CAR-T double-approval in Europe

November 6, 2017 Sales and Marketing CAR-T, Gilead, Juno, Novartis, biotech, drugs, pharma, pharmaceutical

Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma …
News

Top Ten most popular articles on Pharmafile.com this week

November 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
News

GSK’s experimental multiple myeloma scores Breakthrough designation with FDA

November 3, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
News

Tissue Regenix promotes new CEO from within

November 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix

Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …
Appointment

FDA issues warnings in crackdown on baseless cannabis miracle cures

November 2, 2017 Research and Development, Sales and Marketing FDA, cannabidiol, cannabis, pharma

The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …
News

Sanofi Q3 results disappoint due to waning diabetes sales

November 2, 2017 Sales and Marketing Lantus, Sanofi, diabetes, pharma

Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …
News

Allergan ready to take a loss by selling Teva shares

November 2, 2017 Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …
News

Topas Therapeutics brings in new CMO

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Topas Therapeutics, biotech, drugs, pharma, pharmaceutical

Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …
Appointment

CAR-T is bringing true precision to the fight against cancer

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Gilead, Kymriah, Novartis, Yescarta

Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …
Feature

Roche’s Tecentriq approved for funding in UK in bladder cancer

November 1, 2017 Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …
News

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017 Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
News

CEO and President implicated as price-fixing probe widens

November 1, 2017 Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical

A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
News

Shire to streamline operations with 100-strong plant sale and in-house Cinryze production

October 31, 2017 Manufacturing and Production, Sales and Marketing Cinryze, Shire, pharma

Shire has revealed that it plans to sell one of its manufacturing sites in Milford, Massachusetts, having already entered active …
News

Novartis submits second FDA application for CAR-T therapy Kymriah, this time in diffuse large B-cell lymphoma

October 31, 2017 Manufacturing and Production, Sales and Marketing CAR-T, Kymriah, Novartis

Following the “historic” FDA approval of the company’s CAR-T therapy Kymriah (tisagenlecleucel) in the treatment of paediatric and young adults …
News

Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m

October 31, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma

Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026